The conclusions drawn by Shaked and colleagues were that urine could be used to provide a simple, non-invasive test for prion diseases. They also demonstrated the appearance of PrPSc in urine before its accumulation in brain, thus inferring that the PrP urine test could be used during subclinical stages of infection.
